CIK: 0001597549
Total reported value
$152.0M
Reporting period: 2018-03-31 · Number of holdings: 62
Iguana Healthcare Management, LLC disclosed 62 holdings in its latest 13F filing for the period ending 2018-03-31, with total reported value of $152.0M and a quarterly turnover rate of 91.4%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "I"
Iguana Healthcare Management, LLC's disclosed holdings carry a Herfindahl concentration index of 0.027 — mathematically equivalent to about 37 equally-sized positions, well below its 62 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.82), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 14% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim ESPR
-39.4% -$3.6M
Trim 48273J107
-85.7% -$2.7M
Add ARNAEUR
+100.0% $2.3M
Trim BIIB
-20.5% -$2.2M
Trim DERMEUR
0.0% -$2.0M
Trim CI
-20.0% -$1.7M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Spdr S&p 500 ETF Tr | ETF-Large Cap & Growth | 8.66% | +8.66% | NEW | |
| 2 | ESPR | Esperion Therapeutics INC | Stock-Other | 4.76% | -2.32% | -39.39% | |
| 3 | IMMU | Immunomedics INC | Stock-Other | 3.84% | -0.90% | -11.11% | |
| 4 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 3.65% | — | -8.00% | |
| 5 | HUM | Humana INC | Stock-Healthcare | 3.54% | — | -11.11% | |
| 6 | BIIB | Biogen INC | Stock-Healthcare | 3.15% | -1.41% | -20.45% | |
| 7 | MRK | Merck & Co. INC. | Stock-Healthcare | 2.87% | — | — | |
| 8 | ARNAEUR | Arena Pharmaceuticals INC | Stock-Other | 2.60% | +1.49% | +100.00% | |
| 9 | ✓ | Shire PLC | Stock-Other | 2.46% | +2.46% | NEW | |
| 10 | CLVSEUR | Clovis Oncology INC | Stock-Other | 2.43% | — | +16.67% | |
| 11 | ✓ | Esperion Therapeutics INC Ne | Stock-Other | 2.38% | +2.38% | NEW | |
| 12 | ANAB | Anaptysbio INC | Stock-Other | 2.23% | — | -18.75% | |
| 13 | CI | The Cigna Group | Stock-Healthcare | 2.21% | -1.10% | -20.00% | |
| 14 | ✓ | Mylan N V | Stock-Other | 2.17% | +1.07% | +100.00% | |
| 15 | CNC | Centene CORP | Stock-Healthcare | 2.11% | +2.11% | NEW | |
| 16 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 2.08% | — | — | |
| 17 | ALXN | Alexion Pharmaceuticals INC | Stock-Other | 2.02% | +2.02% | NEW | |
| 18 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.01% | — | +20.00% | |
| 19 | ABT | Abbott Laboratories | Stock-Healthcare | 1.97% | -0.82% | -33.33% | |
| 20 | ✓ | Laboratory CORP Amer Hldgs | Stock-Other | 1.86% | +1.86% | NEW | |
| 21 | ADMA | Adma Biologics INC | Stock-Healthcare | 1.82% | — | — | |
| 22 | DXCM | Dexcom INC | Stock-Healthcare | 1.71% | +1.71% | NEW | |
| 23 | ✓ | Gyre Therapeutics INC Com | Stock-Other | 1.70% | +1.70% | NEW | |
| 24 | T8S | Tesaro INC | Stock-Other | 1.69% | — | +28.57% | |
| 25 | ZSANEUR | Zosano Pharma CORP | Stock-Other | 1.66% | +1.66% | NEW | |
| 26 | SGMOQ | Sangamo Therapeutics INC | Stock-Other | 1.56% | — | -16.67% | |
| 27 | RCKT | Rocket Pharmaceuticals INC | Stock-Other | 1.54% | +1.54% | NEW | |
| 28 | GSK | GSK plc ADRhedged | Stock-Healthcare | 1.54% | +0.85% | +100.00% | |
| 29 | MDCOUSD | Medicines Company | Stock-Other | 1.52% | — | +16.67% | |
| 30 | ✓ | Armo Biosciences INC | Stock-Other | 1.48% | +1.48% | NEW | |
| 31 | ✓ | Spdr Series Trust | Stock-Other | 1.44% | +1.44% | NEW | |
| 32 | SRRAEUR | Sierra Oncology INC | Stock-Other | 1.36% | — | +25.00% | |
| 33 | DPLOEUR | Diplomat Pharmacy INC | Stock-Other | 1.33% | +0.68% | +100.00% | |
| 34 | MYOKEUR | Myokardia INC | Stock-Other | 1.28% | — | -20.00% | |
| 35 | CTMX | Cytomx Therapeutics INC | Stock-Other | 1.22% | — | -13.33% | |
| 36 | IOVA | Iovance Biotherapeutics INC | Stock-Other | 1.11% | +1.11% | NEW | |
| 37 | MRTXEUR | Mirati Therapeutics INC | Stock-Other | 1.11% | +1.11% | NEW | |
| 38 | KPTIEUR | Karyopharm Therapeutics INC | Stock-Other | 1.10% | -0.78% | -58.33% | |
| 39 | VKTX | Viking Therapeutics INC | Stock-Healthcare | 1.08% | — | +66.67% | |
| 40 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 0.95% | +0.95% | NEW | |
| 41 | ✓ | Merus N V | Stock-Other | 0.91% | — | -25.00% | |
| 42 | VYGR | Voyager Therapeutics INC | Stock-Other | 0.87% | — | +40.00% | |
| 43 | AKAOQ | Achaogen INC | Stock-Other | 0.85% | — | +33.33% | |
| 44 | ✓ | Corium Intl INC | Stock-Other | 0.83% | — | +22.22% | |
| 45 | INCY | Incyte CORP | Stock-Healthcare | 0.82% | — | +50.00% | |
| 46 | CTLTEUR | Catalent INC | Stock-Other | 0.81% | — | — | |
| 47 | CERNCHF | Cerner CORP | Stock-Other | 0.76% | +0.76% | NEW | |
| 48 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 0.76% | — | — | |
| 49 | XNCR | Xencor INC | Stock-Other | 0.69% | +0.69% | NEW | |
| 50 | KURA | Kura Oncology INC | Stock-Other | 0.62% | +0.62% | NEW |
Not enough priced holdings yet to compute performance
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2018-03-31 | 62 | $152.0M | 91 | |
| 2017-12-31 | 61 | $153.6M | 63 | |
| 2017-09-30 | 68 | $183.5M | 76 | |
| 2017-06-30 | 62 | $176.9M | 82 | |
| 2017-03-31 | 69 | $202.2M | 77 | |
| 2016-12-31 | 60 | $167.3M | 94 | |
| 2016-09-30 | 74 | $281.3M | 87 | |
| 2016-06-30 | 82 | $245.8M | 100 | |
| 2016-03-31 | 75 | $272.9M | 100 | |
| 2015-12-31 | 64 | $303.9M | 100 | |
| 2015-09-30 | 71 | $254.3M | 84 | |
| 2015-06-30 | 69 | $317.0M | 100 | |
| 2015-03-31 | 62 | $237.7M | 100 | |
| 2014-12-31 | 59 | $206.9M | 75 | |
| 2014-09-30 | 62 | $187.2M | 89 | |
| 2014-06-30 | 64 | $214.4M | 92 | |
| 2014-03-31 | 74 | $216.3M | 100 | |
| 2013-12-31 | 70 | $175.5M | 0 |
Iguana Healthcare Management, LLC's most significant position changes for 2018-03-31: New buy: Spdr S&p 500 ETF Tr; Sold out: Celgene CORP (CELG); Sold out: Aerie Pharmaceuticals INC (AERIEUR); Sold out: Abbvie INC (ABBV); New buy: Shire PLC.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ARNAEUR | Arena Pharmaceuticals INC | +1.5% | +100.00% | Add |
| 2 | ✓ | Mylan N V | +1.1% | +100.00% | Add |
| 3 | GSK | GSK plc ADRhedged | +0.9% | +100.00% | Add |
| 4 | DPLOEUR | Diplomat Pharmacy INC | +0.7% | +100.00% | Add |
| 5 | KPTIEUR | Karyopharm Therapeutics INC | -0.8% | -58.33% | Trim |
| 6 | ABT | Abbott Laboratories | -0.8% | -33.33% | Trim |
| 7 | IMMU | Immunomedics INC | -0.9% | -11.11% | Trim |
| 8 | CI | The Cigna Group | -1.1% | -20.00% | Trim |
| 9 | DERMEUR | Dermira INC | -1.3% | — | Unchanged |
| 10 | BIIB | Biogen INC | -1.4% | -20.45% | Trim |
| 11 | ✓ | K2m Group Holdings INC | -1.7% | -85.71% | Trim |
| 12 | ESPR | Esperion Therapeutics INC | -2.3% | -39.39% | Trim |
| 13 | ✓ | Spdr S&p 500 ETF Tr | — | NEW | New buy |
| 14 | CELG | Celgene CORP | — | EXIT | Sold out |
| 15 | AERIEUR | Aerie Pharmaceuticals INC | — | EXIT | Sold out |
| 16 | ABBV | Abbvie INC | — | EXIT | Sold out |
| 17 | ✓ | Shire PLC | — | NEW | New buy |
| 18 | ✓ | Esperion Therapeutics INC Ne | — | NEW | New buy |
| 19 | CNC | Centene CORP | — | NEW | New buy |
| 20 | ALXN | Alexion Pharmaceuticals INC | — | NEW | New buy |
| 21 | ✓ | Laboratory CORP Amer Hldgs | — | NEW | New buy |
| 22 | ✓ | Juno Therapeutics | — | EXIT | Sold out |
| 23 | ZBH | Zimmer Biomet Holdings INC | — | EXIT | Sold out |
| 24 | DXCM | Dexcom INC | — | NEW | New buy |
| 25 | ✓ | Gyre Therapeutics INC Com | — | NEW | New buy |
| 26 | ZSANEUR | Zosano Pharma CORP | — | NEW | New buy |
| 27 | XENTEUR | Intersect Ent INC | — | EXIT | Sold out |
| 28 | RCKT | Rocket Pharmaceuticals INC | — | NEW | New buy |
| 29 | DHR | Danaher CORP | — | EXIT | Sold out |
| 30 | ✓ | Armo Biosciences INC | — | NEW | New buy |
| 31 | ✓ | Spdr Series Trust | — | NEW | New buy |
| 32 | IONS | Ionis Pharmaceuticals INC | — | EXIT | Sold out |
| 33 | SUPN | Supernus Pharmaceuticals INC | — | EXIT | Sold out |
| 34 | PFE | Pfizer INC | — | EXIT | Sold out |
| 35 | WVE | Wave Life Sciences Ltd. | — | EXIT | Sold out |
| 36 | AKCAEUR | Akcea Therapeutics INC | — | EXIT | Sold out |
| 37 | PBYI | Puma Biotechnology INC | — | EXIT | Sold out |
| 38 | ✓ | Clovis Oncology INC | — | EXIT | Sold out |
| 39 | IOVA | Iovance Biotherapeutics INC | — | NEW | New buy |
| 40 | MRTXEUR | Mirati Therapeutics INC | — | NEW | New buy |
| 41 | ✓ | Avexis INC | — | EXIT | Sold out |
| 42 | ✓ | — | EXIT | Sold out | |
| 43 | ✓ | Ablynx NV - Adr | — | EXIT | Sold out |
| 44 | ARWR | Arrowhead Pharmaceuticals In | — | NEW | New buy |
| 45 | BSX | Boston Scientific CORP | — | EXIT | Sold out |
| 46 | CERNCHF | Cerner CORP | — | NEW | New buy |
| 47 | XNCR | Xencor INC | — | NEW | New buy |
| 48 | RGNX | Regenxbio INC | — | EXIT | Sold out |
| 49 | KURA | Kura Oncology INC | — | NEW | New buy |
| 50 | LHCGUSD | Lhc Group INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-16 | Amendment | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-17 | Amendment | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-11-04 | Amendment | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-24 | Amendment | View on EDGAR |
| 2016-03-31 | 2016-05-17 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-16 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-06-10 | Amendment | View on EDGAR |
| 2015-03-31 | 2015-05-18 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-18 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-14 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-14 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-16 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001802279
Total reported value
$152.0M
129 stks
2026-06-30
AUM within 0.0% of this institution
CIK 0001531964
Total reported value
$152.0M
14 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001792510
Total reported value
$152.1M
66 stks
2026-06-30
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0000909661
Total reported value
$17.5B
172 stks
2026-03-31
1 of the top 5 holdings overlap
CIK 0000919185
Total reported value
$3.1B
378 stks
2026-03-31
1 of the top 5 holdings overlap
CIK 0000944388
Total reported value
$108.8B
647 stks
2026-03-31
1 of the top 5 holdings overlap